Gene: HAAO
Official Full Name: 3-hydroxyanthranilate 3,4-dioxygenaseprovided by HGNC
Gene Summary: 3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders. HAAO has been suggested to play a role in disorders associated with altered tissue levels of QUIN. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29247 | HAAO Knockout cell line (HEK293) | Human | HAAO | 1:3~1:6 | Negative | Online Inquiry |
HAAO Gene Knockout Cell Lines are genetically modified cell lines that have had the HAAO gene effectively disrupted or inactivated. This precision enables researchers to investigate the functional role of HAAO in various biological processes, including metabolic pathways, cellular signaling, and disease mechanisms. Utilizing advanced CRISPR-Cas9 technology, these cell lines allow for targeted gene editing, ensuring high specificity and minimal off-target effects, thus providing a reliable tool for molecular biology research.
The primary function of HAAO is its involvement in the catabolism of tryptophan, specifically converting 3-hydroxyanthranilic acid into quinolinic acid, which plays a significant role in the biosynthesis of nicotinamide adenine dinucleotide (NAD+). By employing HAAO Gene Knockout Cell Lines, researchers can dissect the metabolic consequences of HAAO ablation, enabling studies in areas such as neurodegeneration, metabolic disorders, and cancer biology. The knockout model provides an invaluable platform for uncovering the underlying mechanisms of diseases linked to tryptophan metabolism.
In research and clinical settings, these cell lines present a considerable advancement over traditional models that lack precision. Unlike general knockdown approaches, which may only partially inhibit gene expression, complete knockout enables researchers to observe the full impact of gene loss, making it a powerful asset for both fundamental and applied research. As such, this product provides researchers with a high-fidelity model for testing therapeutic approaches and understanding disease etiologies that involve the HAAO pathway.
The distinct advantage of HAAO Gene Knockout Cell Lines lies in their robustness and reproducibility compared to other genetically modified systems. Researchers can confidently rely on the data generated from these cell lines, which can yield consistent experimental outcomes, leading to increased efficiency in drug discovery and toxicity testing.
Given our company's extensive expertise in genetic engineering and commitment to providing high-quality biological products, we ensure that HAAO Gene Knockout Cell Lines meet stringent quality standards and serve as a reliable foundation for innovative research. Investing in these cell lines not only enhances scientific inquiry but also enables the advancement of therapeutic strategies in clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.